Get startedLog in
    Picture of Abivax SA logo

    ABVX — Abivax SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapSucker Stock
    All News

    Brief: Abivax Achieves Key Milestone In Phase 3 Abtect Trial Enrollment

    Picture of Abivax SA logoAbivax SA
    09/01/2025 16:56
    Jan 9 (Reuters) - Abivax SA  ABVX.PA :
    * ABIVAX ACHIEVES KEY MILESTONE IN PHASE 3 ABTECT TRIAL
ENROLLMENT
    * TOP-LINE RESULTS FOR 8-WEEK INDUCTION TRIAL EXPECTED IN Q3
2025
    * ENROLLMENT COMPLETION EXPECTED IN Q2 2025
    * PHASE 3 ABTECT TRIAL REACHES 82% OF TARGET ENROLLMENT

Source text:  urn:newsml:reuters.com:*:nGNXb5Lpc9
Further company coverage:  ABVX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

    Recent news on Abivax SA

    See all news